NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

RecruitingN/A

Sponsor: AstraZeneca

Conditions: Chronic Rhinosinusitis With Nasal Polyps

Interventions: Endoscopic Sinus Surgery (ESS)

Countries: China

This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Participant must be 16 years of age or older, at the time of signing the informed consent.
2. Participants with a documented diagnosis of CRSwNP.
3. Endoscopic nasal polypectomy is performed during the screening period.
4. Voluntarily participate and sign the informed consent form as described in A 3.
5. No history or current psychiatric disorders, with normal cognitive functions including understanding, expression, and orientation.

Exclusion Criteria:

1. Any significant disease or disorder that the investigator believes may place the patient at risk or may affect the study results or the patient's ability to participate in the study.
2. Currently participating in an interventional study.
3. Patients who are unable to independently complete questionnaires due to language barriers or mental status.

Locations (18)

Changchun, China
Changsha, China
Chengdu, China
Guangzhou, China
Guangzhou, China
Guangzhou, China
Haikou, China
Kunming, China
Nanchang, China
Nanjing, China
Nanning, China
Qingdao, China
Shanghai, China
Shenzhen, China
Ürümqi, China
Wuhan, China
Wuhan, China
Xiamen, China